Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | ABVX | HCXLY |
|---|---|---|
| Price | $91.73 | $51.76 |
| Change today | ▼ 1.24% | ▲ 8.15% |
| Market cap | $8.01B | $7.99B |
| Return, 3 months | -35.5% | -0.7% |
| Return, year to date | -32.0% | – |
| Return, 1 year | +5.8% | – |
| P/E (TTM) | -15.3 | 13.7 |
| P/B | 19.5 | 2.1 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | – | 2.07% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | – |
| Analyst buy share | – | – |
| RSI (14) | 33 | 51 |
| 30-day volatility | 48.1% | 58.2% |
| Max drawdown, 1 year | -50.1% | -16.2% |
| Trend read | Strong downtrend | Strong uptrend |
| Analyst consensus | – | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.